´ëÇÑ°£ÇÐȸ (¿Â¶óÀÎ)The Liver Week 2020 Virtual Confernence Day 2 : 2020-08-14±³À°ÀÏÀÚ : 2020-08-14
±³À°Àå¼Ò : ¿Â¶óÀÎ Çмú´ëȸ
±³À°ÁÖÁ¦ :
(¿Â¶óÀÎ)The Liver Week 2020 Virtual Confernence Day 2 ÁÖÃÖ±â°ü : ´ëÇÑ°£ÇÐȸ
´ã´çÀÚ : ´ëÇÑ°£ÇÐȸ
¿¬¶ôó : 02-707-0091
À̸ÞÀÏ :
kasl@kams.or.kr ±³À°Á¾·ù : ³»°ú
Âü¼®¿¹»óÀοø : 1000¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 18 ½Ã°£ 10ºÐ
¼¼ºÎ¼ö°·á : 60,000¿ø
ºñ°í Member-KRW 50,000/Resident, Trainee, Nurse, Army Doctor, Others-KRW 30,000Non-Member, Healthcare Professional-KRW 60,000
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 08¿ù 14ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 08:30~09:00 Hepatitis C Elimination Program in Taiwan: ¡°The Taiwan Hepatitis C Policy Guideline 2018 - 2025¡± Chien-Jen Chen(Former Vice President of Taiwan, Academia Sinica, Taiwan)
±³À°½Ã°£ 08¿ù 14ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 09:00~09:20 HCV Elimination in Taiwan: What and How We Have Achieved the Beginning till Today Jia-Horng Kao(National Taiwan Univ., Taiwan)
±³À°½Ã°£ 08¿ù 14ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 09:00~09:40 HCV Elimination in Japan: The Japanese Policy and Outcome Tatsuya Kanto(National Center for Global Health and Medicine, Japan)
±³À°½Ã°£ 08¿ù 14ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 09:40~10:00 National Policies on Hepatitis C in Korea Hyung-Min Lee(Korea Centers for Disease Control & Prevention)
±³À°½Ã°£ 08¿ù 14ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 10:00~10:20 Current Status and Suggestions for Hepatitis C Control in Korea Do Young Kim(Yonsei Univ.)
Åä·Ð 08¿ù 14ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 10:20~10:50 Panel Discussion ()
±³À°½Ã°£ 08¿ù 14ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 08:30~08:50 Hippo Pathway Regulation of Liver Inflammation and Cancer Yingzi Yang(Harvard Univ., USA)
±³À°½Ã°£ 08¿ù 14ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 08:50~09:10 Complement C3, tRNA-derived Fragments Gly-tRFs, and Alcoholic Liver Disease Songqing He(Guangxi Medical Univ., China)
±³À°½Ã°£ 08¿ù 14ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 09:10~09:30 Autophagy and Cancer Wen-Xing Ding(Univ. of Kensas, USA)
±³À°½Ã°£ 08¿ù 14ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 09:30~09:50 Risk Factors for Alcohol-Related Hepatocellular Carcinoma Makiko Taniai(Tokyo Women¡¯s Medical Univ., Japan)
±³À°½Ã°£ 08¿ù 14ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 09:50~10:00 Catecholamine Signaling Pathway Protects Alcoholic Fatty Liver by Inducing Growth Differentiation Factor 15 Hee-Hoon Kim(KAIST)
Åä·Ð 08¿ù 14ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 10:00~10:20 Round Table Discussions ()
±³À°½Ã°£ 08¿ù 14ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 08:30~08:50 Tranomic Signature of Nonalcoholic Fatty Liver Disease Murim Choi(Seoul National Univ.)
±³À°½Ã°£ 08¿ù 14ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 08:50~09:10 Immunologic Circuits of Hepatocellular Carcinoma Su Jong Yu(Seoul National Univ.)
±³À°½Ã°£ 08¿ù 14ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 09:10~09:30 Interactive Interface between Gut Microbiome and Immunome in Alcohol-Related Liver Disease Bernd Schnabl(Univ. of California San Diego, USA)
±³À°½Ã°£ 08¿ù 14ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 09:30~09:50 Novel Immunomodulating Pharmabiotics for Hepatocellular Carcinoma Han Soo Park(GIST)
±³À°½Ã°£ 08¿ù 14ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 09:50~10:10 Pathology of Autoimmune Hepatitis, Primary Biliary Cholangitis, and Overlap Syndrome Masayoshi Kage(Kurume Univ., Japan)
±³À°½Ã°£ 08¿ù 14ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 10:10~10:30 Autoimmune Hepatitis: From Bench to Clinic Xiong Ma(Shanghai Jiao Tong Univ., China)
±³À°½Ã°£ 08¿ù 14ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 10:30~10:50 Primary Biliary Cholangitis: Unsolved Issues and New Treatment Gideon M. Hirschfield(Univ. of Birmingham, UK)
±³À°½Ã°£ 08¿ù 14ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 10:30~10:50 Prognostic Potential of LncRNAs for Alcoholic Liver Disease Patients Suthat Liangpunsakul(Indiana Univ., USA)
±³À°½Ã°£ 08¿ù 14ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 10:50~11:10 Predictors of Steroid Non-Response and New Approaches in Severe Alcoholic Hepatitis Shiv Kumar Sarin(Institute of Liver and Biliary Science, India)
±³À°½Ã°£ 08¿ù 14ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 11:10~11:30 Global and Regional Impacts of Alcoholism Use on Public Health Dong Joon Kim(Hallym Univ.)
±³À°½Ã°£ 08¿ù 14ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 11:30~11:50 Impact of Genetic Traits and Drinking Mode on Alcoholic Liver Disease in China Jia Xiao(Fujian Normal Univ., China)
±³À°½Ã°£ 08¿ù 14ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 11:50~12:10 TAPPY: Multi-Professional Care of Alcoholic Patients Masahiro Kikuchi(Tokyo Medical Center, Japan)
±³À°½Ã°£ 08¿ù 14ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 12:10~12:20 The Evolution of Liver Donor Liver Transplantation for Alcoholic Liver Cirrhosis in a High-Volume Center: The Eastern Perspective Jeffrey Samuel Co(Kaohsiung Chang Memorial Hospital, Taiwan)
Åä·Ð 08¿ù 14ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 12:20~12:40 Round Table Discussions ()
±³À°½Ã°£ 08¿ù 14ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 11:00~12:00 Plenary Presentation 2 Jin Mo YangYang Won Nah(The Catholic Univ. of KoreaUniv. of Ulsan)
±³À°½Ã°£ 08¿ù 14ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 13:00~13:20 Locoregional Therapy Yoon Jun Kim(Seoul National Univ.)
±³À°½Ã°£ 08¿ù 14ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 13:20~13:40 Down-Staging Living Donor Liver Transplantation Jae Geun Lee(Yonsei Univ.)
±³À°½Ã°£ 08¿ù 14ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 13:40~14:00 Is There a Role for TKIs and Immune Checkpoint Inhibitors? Thomas Yau(Univ. of Hong Kong, China)
Åä·Ð 08¿ù 14ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 14:00~14:10 Discussion ()
±³À°½Ã°£ 08¿ù 14ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 13:00~13:20 Established and Potential Biomarkers of Hepatocellular Carcinoma with Focus on Recent Clinical Trials Joong-Won Park(National Cancer Center Korea)
±³À°½Ã°£ 08¿ù 14ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 13:20~13:40 Imaging Biomarkers in the Era of Precision Medicine Gyongyi Szabo(Harvard Univ., USA)
±³À°½Ã°£ 08¿ù 14ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 13:40~14:00 Pathologic Biomarkers that Indicate the Aggressiveness and Prognosis of Hepatocellular Carcinoma Young Nyun Park(Yonsei Univ.)
±³À°½Ã°£ 08¿ù 14ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 13:30~14:40 General Oral Presentation 2 (*K) Young Oh KweonSang-Jae Park(Kyungpook National Univ.National Cancer Center Korea)
±³À°½Ã°£ 08¿ù 14ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 14:10~14:30 Tumor Localization in Oncologic Surgery Masaki Ueno(Wakayama Medical Univ., Japan)
±³À°½Ã°£ 08¿ù 14ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 14:30~14:50 Anatomical Liver Resection Dai Hoon Han(Yonsei Univ.)
±³À°½Ã°£ 08¿ù 14ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 14:50~15:10 Donor Hepatectomy Young Rock Choi(Seoul National Univ.)
±³À°½Ã°£ 08¿ù 14ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 14:20~15:20 KASL Plenary Presentation Seong Gyu Hwang(CHA Univ.)
±³À°½Ã°£ 08¿ù 14ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 15:20~15:40 New and Old Biomarkers for Diagnosis and Management of Chronic Hepatitis B Infection Il Han Song(Dankook Univ.)
±³À°½Ã°£ 08¿ù 14ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 15:40~16:00 Non-Invasive Diagnosis and Biomarkers in Alcohol-Related Liver Disease Suthat Liangpunsakul(Indiana Univ., USA)
±³À°½Ã°£ 08¿ù 14ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 16:00~16:20 Quantitative Imaging Biomarker in the Assessment of Hepatic Fibrosis and Steatosis Woo Kyoung Jeong(Sungkyunkwan Univ.)
±³À°½Ã°£ 08¿ù 14ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 16:20~16:40 Clinical Application of Liquid Biopsy as a Prognostic Biomarker in Hepatocellular Carcinoma Soo Young Park(Kyungpook National Univ.)
±³À°½Ã°£ 08¿ù 14ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 15:30~15:50 Liver Transplantation for Patients with Severe Alcoholic Hepatitis: Inside Stories of Patient Selection and Pretransplant Management Philippe Mathurin(Chu De Lille, France)
±³À°½Ã°£ 08¿ù 14ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 15:50~16:10 Risk Stratification and Optimal Management for Liver Transplantation in Acute-on-Chronic Liver Failure Dong Hyun Sinn(Sungkyunkwan Univ.)
±³À°½Ã°£ 08¿ù 14ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 16:10~16:30 Risk Stratification and Optimal Management for Liver Transplantation in Acute Liver Failure Young-dong Yu(Korea Univ.)
±³À°½Ã°£ 08¿ù 14ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 16:30~16:50 How to Improve Post-Transplant Outcomes in Patients with High MELD Scores Dong-Hwan Jung(Univ. of Ulsan)
Åä·Ð 08¿ù 14ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 16:50~17:00 Discussion ()